Outcomes of patients with resected stage III/IV acral or mucosal melanoma treated with adjuvant anti-PD-1 therapy

被引:3
|
作者
Jacques, S. K. [1 ]
McKeown, J. [2 ]
Grover, P. [3 ]
Park, B. [4 ]
Zaremba, A. [5 ]
Dimitriou, F. [6 ]
Rashid, M. F. Harunal [7 ]
Namikawa, K. [8 ]
Mooradian, M. [9 ]
Placzke, J. [10 ]
Allayous, C. [11 ]
Mehmi, I. [12 ]
DePalo, D. [13 ]
Wicky, A. [14 ]
Schwarze, J. K. [15 ]
Nakamura, Y. [16 ]
Benannoune, N. [17 ]
Menzies, A. M. [18 ]
Lo, S. N. [19 ]
Carlino, M. S. [1 ]
机构
[1] Crown Princess Mary Canc Ctr Westmead, Med Oncol Dept, Westmead, NSW, Australia
[2] Melanoma Inst Australia, Biostat, Wollstonecraft, NSW, Australia
[3] Melanoma Inst Australia, Med Oncol, Wollstonecraft, NSW, Australia
[4] Vanderbilt Univ, Med Ctr, Med Oncol, Nashville, TN USA
[5] Univ Klinikum Essen, Dermatol, Essen, Germany
[6] USZ Univ Zurich Hosp, Dermatol Dept, Zurich, Switzerland
[7] NCCS Natl Canc Ctr Singapore, Med Oncol Dept, Singapore, Singapore
[8] NCCH Natl Canc Ctr Hosp, Dermatol Oncol Dept, Chuo Ku, Tokyo, Japan
[9] Massachusetts Gen Hosp, Ctr Canc, Oncol, Boston, MA USA
[10] Maria Sklodowska Curie Natl Res Inst Oncol, Soft Tissue & Bone Sarcoma & Melanoma Clin, Warsaw, Poland
[11] Hop St Louis, AP HP, Med Oncol, Paris, France
[12] Angeles Clin & Res Inst, Med Oncol, Santa Monica, CA USA
[13] H Lee Moffitt Canc Ctr & Res Inst, Med Oncol, Magnolia Campus, Tampa, FL USA
[14] CHUV Ctr Hosp Univ Vaudois, Oncol Dept, Batiment Agora, Lausanne, Switzerland
[15] Univ Ziekenhuis Brussel, Med Oncol, Jette, Belgium
[16] Saitama Med Univ, Int Med Ctr, Dept Skin Oncol Dermatol, Hidaka, Japan
[17] Gustave Roussy, Med Oncol, Canc Campus, Villejuif, France
[18] Melanoma Inst Australia, Med Oncol Dept, Suite 5-6, Wollstonecraft, NSW, Australia
[19] Univ Sydney, Sch Publ Hlth, Melanoma Inst Australia, Sydney, NSW, Australia
关键词
D O I
10.1016/j.annonc.2022.07.935
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
809P
引用
收藏
页码:S915 / S916
页数:2
相关论文
共 50 条
  • [41] Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanoma
    Patrinely, James R., Jr.
    Baker, Laura X.
    Davis, Elizabeth J.
    Song, Haocan
    Ye, Fei
    Johnson, Douglas B.
    [J]. CANCER, 2020, 126 (15) : 3448 - 3455
  • [42] Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy
    Owen, C. N.
    Shoushtari, A. N.
    Chauhan, D.
    Palmieri, D. J.
    Lee, B.
    Rohaan, M. W.
    Mangana, J.
    Atkinson, V
    Zaman, F.
    Young, A.
    Hoeller, C.
    Hersey, P.
    Dummer, R.
    Khattak, M. A.
    Millward, M.
    Patel, S. P.
    Haydon, A.
    Johnson, D. B.
    Lo, S.
    Blank, C. U.
    Sandhu, S.
    Carlino, M. S.
    Larkin, J. M. G.
    Menzies, A. M.
    Long, G., V
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (08) : 1075 - 1082
  • [43] Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy
    Woodford, Rachel
    McKeown, Janet
    Hoeijmakers, Lotte L.
    Mangana, Johanna
    Dimitriou, Florentia
    Allayous, Clara
    Zaman, Farzana
    Aya, Francisco
    Marsiglio, John
    Goodman, Rachel
    Rayson, Victoria
    Placzke, Joanna
    Kessels, Jolien
    Ramalyte, Egle
    Haque, Waqas
    Wilson, Isabella
    Trojaniello, Claudia
    Benannoune, Naima
    Roberts-Thomson, Rachel
    Robert, Caroline
    Blank, Christian U.
    Dummer, Reinhard
    Lebbe, Celeste
    Haydon, Andrew
    Arance, Ana
    Hu-Lieskovan, Siwen
    Johnson, Douglas B.
    Mcarthur, Grant A.
    Rutkowski, Piotr
    Neyns, Bart
    Sullivan, Ryan J.
    Weber, Jeffrey
    Carlino, Matteo S.
    Ascierto, Paolo A.
    Lo, Serigne
    Long, Georgina, V
    Menzies, Alexander M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [44] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
    Parakh, Sagun
    Park, John J.
    Mendis, Shehara
    Rai, Rajat
    Xu, Wen
    Lo, Serigne
    Drummond, Martin
    Rowe, Catherine
    Wong, Annie
    McArthur, Grant
    Haydon, Andrew
    Andrews, Miles C.
    Cebon, Jonathan
    Guminski, Alex
    Kefford, Richard F.
    Long, Georgina V.
    Menzies, Alexander M.
    Klein, Oliver
    Carlino, Matteo S.
    [J]. BRITISH JOURNAL OF CANCER, 2017, 116 (12) : 1558 - 1563
  • [45] Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study
    Christensen, Stine K.
    Winther, Mette L.
    Laursen, Ida J.
    Madsen, Freja S.
    Brink, Carsten
    Brix, Thomas H.
    Ellebaek, Eva
    Svane, Inge Marie
    Hansen, Frederikke S.
    Haslund, Charlotte
    Laursen, Olivia K.
    Schmidt, Henrik
    Larsen, Ida D.
    Bastholt, Lars
    Ruhlmann, Christina H.
    [J]. SUPPORTIVE CARE IN CANCER, 2024, 32 (05)
  • [46] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
    Park, J. J.
    Parakh, S.
    Mendis, S.
    Rai, R.
    Lo, S.
    Haydon, A.
    Andrews, M. C.
    Cebon, J.
    Guminski, A.
    Kefford, R.
    Long, G. V.
    Menzies, A. M.
    Klein, O.
    Carlino, M. S.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [47] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
    Sagun Parakh
    John J Park
    Shehara Mendis
    Rajat Rai
    Wen Xu
    Serigne Lo
    Martin Drummond
    Catherine Rowe
    Annie Wong
    Grant McArthur
    Andrew Haydon
    Miles C Andrews
    Jonathan Cebon
    Alex Guminski
    Richard F Kefford
    Georgina V Long
    Alexander M Menzies
    Oliver Klein
    Matteo S Carlino
    [J]. British Journal of Cancer, 2017, 116 : 1558 - 1563
  • [48] REAL-WORLD OUTCOMES OF PATIENTS WITH RESECTED STAGE IIIA MELANOMA TREATED WITH ADJUVANT NIVOLUMAB
    Samlowski, Wolfram
    Nicholas, Robert
    Poretta, Tayla
    Moshyk, Andriy
    Rajkumar, Jonathan
    Salvatore, Anthony
    Stwalley, Brian
    Nwokeji, Esmond
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A131 - A131
  • [49] Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma
    Patrinely, J. Randall, Jr.
    Johnson, Rebecca
    Lawless, Aleigha R.
    Bhave, Prachi
    Sawyers, Amelia
    Dimitrova, Maya
    Yeoh, Hui Ling
    Palmeri, Marisa
    Ye, Fei
    Fan, Run
    Davis, Elizabeth J.
    Rapisuwon, Suthee
    Long, Georgina V.
    Haydon, Andrew
    Osman, Iman
    Mehnert, Janice M.
    Carlino, Matteo S.
    Sullivan, Ryan J.
    Menzies, Alexander M.
    Johnson, Douglas B.
    [J]. JAMA ONCOLOGY, 2021, 7 (05) : 744 - 748
  • [50] A real-world study of adjuvant anti-PD-1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations
    Sun, Wei
    Xu, Yu
    Yan, WangJun
    Wang, ChunMeng
    Hu, Tu
    Luo, ZhiGuo
    Zhang, XiaoWei
    Liu, Xin
    Chen, Yong
    [J]. CANCER MEDICINE, 2023, 12 (15): : 15945 - 15954